Article
DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update
23 Oct 2008
Abstract excerpt
Lung cancer is the number one cancer killer in the United States. This disease is clinically divided into two sub-types, small cell lung cancer, (10-15% of lung cancer cases), and non-small cell lung cancer (NSCLC; 85-90% of cases). Early detection of NSCLC, which is the more common and less aggressive of the two sub-types, has the highest potential for saving lives. As yet, no routine screening method that...
Topics
Join the communities discussing this publication.